Can you use your HSA or FSA for testosterone replacement therapy? Yes, in most cases. Learn which TRT expenses qualify, how much TRT costs monthly, what insurance covers, and how Medicare handles testosterone therapy.
A guide to long-term testosterone replacement therapy dosing, covering standard protocols, daily microdosing, intramuscular vs subcutaneous injection, and step-by-step injection technique.
A guide to Medicare coverage for testosterone replacement therapy, including Part B vs Part D rules, prior authorization steps, real 2025 costs, and strategies to reduce out-of-pocket spending.
Evidence-based guide covering testosterone cypionate dosing, injection frequency, side effects, and how it compares to enanthate, propionate, pellets, and gel for men on TRT.
A guide to testosterone propionate covering half-life, dosing protocols, injection frequency, side effects, and how it compares to cypionate, enanthate, pellets, and gel formulations.
What cold-exposure studies establish about exercise recovery, and what they do not establish about TRT dosing, injection timing, fertility or supplements.
Separate TSA screening, international entry rules, and exact-product storage before flying with testosterone, syringes, or gel.
Does testosterone replacement therapy cause hair loss? Learn the DHT mechanism, who is genuinely at risk, how to monitor for shedding on TRT, and which treatments can protect hair without stopping therapy.
A guide covering how testosterone replacement therapy interacts with statins, how each drug affects your lipid panel, what labs to monitor, and how to manage TRT alongside supplements and lifestyle factors.
Learn how testosterone replacement therapy (TRT) affects libido, who qualifies, what doses are used, and what the clinical evidence says about restoring sex drive in men with hypogonadism.
Testosterone replacement therapy can improve insulin sensitivity, reduce visceral fat, and restore libido in men with hypogonadism and metabolic syndrome. Learn the evidence, doses, and protocols.
A clinical guide to TRT prior authorization requirements, insurance coverage rules, Medicare policies, and real monthly cost breakdowns for testosterone replacement therapy in 2025.
Creatine cypionate isn't a single product. Creatine monohydrate is the 3-5 g/day supplement; testosterone cypionate is injectable TRT. They don't interact.
A guide to combining testosterone replacement therapy with peptides. Covers GH secretagogues, BPC-157, TB-500, and age-specific protocols for men over 50, men over 65, younger men, and bodybuilders.
A guide to getting testosterone cream (transdermal TRT) safely through a legitimate online telehealth provider, covering who qualifies, how to read labs, what to expect, and red flags to avoid.
Perimenopause triggers dramatic swings in estrogen and progesterone that destabilize serotonin, dopamine, GABA, and norepinephrine. Learn exactly why your brain chemistry changes after 40 and what clinical options can help.
A guide covering diet, exercise, sleep, stress, and lifestyle strategies that have demonstrated measurable effects on testosterone levels in peer-reviewed trials.
A comparison of compounded and branded metformin, covering bioequivalence, cost, formulation differences, safety, and how to choose the right option for type 2 diabetes or prediabetes management.
A guide to using metformin in NAFLD / MASLD patients: what the trials actually show, how to dose it, who benefits most, and where newer agents fit in.
Standard metformin dosing starts at 500mg with meals, up to 2,000mg daily max. Lowers HbA1c 1.0-1.5 points; backed by UKPDS 34 trial data.
Metformin is avoided in severe liver disease (Child-Pugh C or AST/ALT over 3x ULN); mild-to-moderate cases may use cautious low-dose therapy.
An evidence-based look at how metformin affects mental health and mood, covering depression, cognitive function, anxiety, B12 depletion, and clinical management guidance.
A clinical review of metformin microdosing protocols for type 2 diabetes, prediabetes, longevity, and off-label use. Covers dosing thresholds, tolerability data, titration schedules, and what current guidelines do and do not support.
A clinical deep-dive into metformin use after bariatric surgery, covering pharmacokinetics, B12 depletion, RYGB vs sleeve gastrectomy differences, dosing, and when to stop or restart.
When and how to safely restart metformin after acute illness, hospitalization, or surgery. Evidence-based guidance covering lactic acidosis risk, renal thresholds, contrast dye rules, and step-by-step restart protocols.
A deep dive into metformin real-world evidence from major registries and RWE studies, covering mechanism, cardiovascular outcomes, cancer signals, and how registry data compares to RCT findings.
How temperature extremes, seasonal illness, hydration shifts, and activity changes affect metformin dosing, safety, and efficacy across all four seasons. MD/PharmD-level guidance with primary-literature citations.
A clinician-level guide to metformin dosing, safety, and pharmacology in transplant recipients, people living with HIV, older adults, pregnant patients, and other special populations. Evidence-based, PubMed-cited.
How metformin dosing, GI tolerability, contrast imaging, and altitude exposure interact during travel, with a clinician-discussion and monitoring framework for patients and prescribers.
Starting doses run 10 to 40 mg/day, tapering to 5 to 10 mg maintenance after 4 to 8 weeks. About 50% reach remission by 12 to 18 months.
A guide to how methimazole affects appetite and food cravings in hyperthyroid patients, including the thyroid-metabolic axis, expected timelines, and when appetite changes signal a problem.
A full clinical review of methimazole-induced and hyperthyroidism-related hair and skin changes, including alopecia, urticaria, and vasculitis, with primary-literature citations and management guidance.
A clinical guide to the risk of hyperthyroidism returning after stopping methimazole: who is more likely to relapse, what the evidence actually supports, how tapering is typically approached, and when to escalate to definitive therapy.
What happens when you take too much MK-677 (ibutamoren)? A guide covering mechanism, overdose signs, dose thresholds, and clinical management with primary-source citations.
A clinical deep-dive into MK-677 (ibutamoren) dosing adjustments for patients with renal impairment, covering pharmacokinetics, GH/IGF-1 physiology, trial data, and prescriber guidance.
A deep dive into MK-677 (ibutamoren) safety signals, FDA enforcement actions, mechanism of action, and what the clinical trial record actually shows about risks at every dose studied.
A analysis of how MK-677 (ibutamoren) affects sleep architecture, REM and slow-wave sleep duration, GH pulse timing, and what the clinical trial data mean for patients and clinicians.
Standard adult modafinil starting dose is 200 mg each morning, up to 400 mg max. See timing for narcolepsy, shift work, OSA, and liver dose adjustments.
A clinician-level review of modafinil (Provigil) use in patients with autoimmune disease, covering pharmacology, immune interactions, drug-drug interactions with immunosuppressants, and monitoring protocols.
A deep dive into how modafinil (Provigil) affects cognitive function, covering mechanism, evidence quality by population, dosing considerations, risks, and who is most likely to benefit.
A physician-level comparison of compounded modafinil vs branded Provigil, covering FDA status, bioequivalence, cost, clinical trial data, and when each option may be appropriate.
A clinician-level review of MOTS-c mitochondrial peptide and its effects on bone mineral density, osteoblast activity, AMPK signaling, and potential use in osteoporosis research.
A deep dive into how the mitochondrial peptide MOTS-c affects cardiovascular risk, lipid metabolism, vascular function, and cardiac remodeling, covering the latest preclinical and emerging clinical data.
A clinical deep-dive into MOTS-c mitochondrial peptide and its muscle preservation mechanisms, covering trial data, dosing frameworks, and practical protocols prepared by the HealthRX.com Editorial Team.
A clinician-level review of how the mitochondrial peptide MOTS-c may influence sleep architecture, circadian signaling, and metabolic recovery during sleep, with primary-literature citations and a practical clinical framework.
A clinician-level review of tirzepatide's effects on mood, depression, anxiety, and cognitive function, including trial data, proposed mechanisms, and what to watch for during treatment.
Evidence-based strategies to preserve lean muscle mass while losing weight on Mounjaro (tirzepatide), including protein targets, resistance training protocols, and lab monitoring guidance prepared by the HealthRX.com Editorial Team.
Evidence-based guidance on when to stop Mounjaro (tirzepatide) before surgery, why gastroparesis risk drives anesthesia concerns, and how to coordinate your hold with your surgical team.
NMN trials show no BP increase; one study found systolic BP dropped ~6 mmHg at 250mg/day over 12 weeks. Long-term cardiac data still limited.
A practical guide to NMN and NR with meals, alcohol, other supplements, warfarin, diabetes medicines, and cancer treatment, with cited human studies.
A guide to monitoring NMN and NR supplementation in adults 65 and older, covering NAD+ levels, renal function, drug interactions, metabolic markers, and safety checkpoints.
A breakdown of NMN and NR (nicotinamide mononucleotide and nicotinamide riboside) as NAD+ precursors for muscle preservation, covering clinical trial data, dosing protocols, and who benefits most.
A guide to the safety of nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) supplements for adults aged 50 to 64, covering trial data, drug interactions, dosing, and red flags.
A guide to monitoring NMN and NR supplementation in adults aged 18 to 29, covering baseline labs, safety signals, fertility considerations, and how to interpret changes in NAD+ biomarkers.
A evidence summary on CJC-1295 (modified GRF) used off-label for longevity. Covers mechanism, clinical trial data, safety, GRADE evidence level, and what the FDA has approved.
Enclomiphene citrate is used off-label to raise LH, FSH, and testosterone in men with secondary hypogonadism while preserving sperm production. This article reviews the trial evidence, compares it to clomiphene, and outlines a monitoring framework for clinician discussion.
Can an estradiol patch treat osteoporosis? This HealthRX.com clinical guide covers the off-label evidence, bone-density data, FDA-approved alternatives, and the risk-benefit tradeoffs physicians weigh before prescribing transdermal estradiol for bone loss.
A comprehensive clinical guide to off-label estradiol transdermal use in transgender hormone therapy, covering evidence quality, dosing protocols, lab monitoring intervals, and safety considerations prepared by the HealthRX.com Editorial Team.
A guide to off-label finasteride use in gender-affirming care, covering mechanism, dosing protocols, evidence quality, safety monitoring, and FDA-approved context.
A guide to ipamorelin acetate for fat loss, covering off-label status, available clinical evidence, dosing protocols, and monitoring requirements.